The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Nutr.
Sec. Nutrition, Psychology and Brain Health
Volume 11 - 2024 |
doi: 10.3389/fnut.2024.1456111
This article is part of the Research Topic Effects of Probiotics, Prebiotics, and Postbiotics on Microbiota-Gut-Brain Axis View all 4 articles
Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants -a pilot observational study
Provisionally accepted- 1 Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, United States
- 2 University of Minnesota Genomic Center, Minneapolis, Minnesota, United States
- 3 Department of Psychology, College of Liberal Arts, University of Minnesota, Minneapolis, Minnesota, United States
- 4 Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States
- 5 HealthPartners Institute for Education and Research, Bloomington, Minnesota, United States
- 6 Harold Hamm Diabetes Center, College of Medicine, University of Oklahoma, Norman, Oklahoma, United States
- 7 Department of Computer Science and Engineering, College of Science and Engineering, University of Minnesota, Minnesota, Minnesota, United States
- 8 Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Women's Heath, Medical School, University of Minnesota, Minneapolis, Minnesota, United States
- 9 Pregnancy and Child Health Research Center, HealthPartners Institute for Education and Research, Bloomington, Illinois, United States
Early life gut microbiomes are important for brain and immune system development in animal models. Probiotic use has been proposed as a strategy to promote health via modulation of microbiomes. In this observational study, we explore if early life exposure to probiotics via the mother during pregnancy and lactation, is associated with decreased inflammation in breastmilk, maternal and infant microbiome variation, and altered infant neurodevelopmental features. Methods: Exclusively breastfeeding mother-infant dyads were recruited as part of the "Mothers and Infants Linked for Healthy Growth (MILk) Study". Probiotic comparison groups were defined by exposure to maternal probiotics (NO/YES) and by timing of probiotic exposure (prenatal, postnatal, total). C-reactive protein (CRP) and IL-6 levels were determined in breastmilk by immunoassays, and microbiomes were characterized from 1-month milk and from 1-and 6-month infant feces by 16S rDNA sequencing. Infant brain function was profiled via electroencephalogram (EEG); we assessed recognition memory using event-related potential (ERP) responses to familiar and novel auditory (1 month) and visual (6 months) stimuli. Statistical comparisons of study outcomes between probiotic groups were performed using permutational analysis of variance (PERMANOVA) (microbiome) and linear models (all other study outcomes), including relevant covariables as indicated. Results: We observed associations between probiotic exposure and lower breastmilk CRP and IL-6 levels, and infant gut microbiome variation at 1-and 6-months of age (including higher abundances of Bifidobacteria and Lactobacillus). In addition, maternal probiotic exposure was associated with differences in infant ERP features at 6-months of age. Specifically, infants who were exposed to postnatal maternal probiotics (between the 1-and 6-month study visits) via breastfeeding/breastmilk, had larger differential responses between familiar and novel visual stimuli with respect to the late slow wave component of the EEG, which may indicate greater memory updating potential. The milk of mothers of this subgroup of infants had lower IL-6 levels and infants had different 6-month fecal microbiomes as compared to those in the "NO" maternal probiotics group. Discussion: These results support continued research into "Microbiota-Gut-Brain" connections during early life and the role of pre-and postnatal probiotics in mothers to promote healthy microbiome-associated outcomes in infants.
Keywords: Probiotics1, gut microbiome2, infant3, inflammation4, neurodevelopment5, Event related potential6, Breastmilk7
Received: 28 Jun 2024; Accepted: 02 Sep 2024.
Copyright: © 2024 Gonia, Heisel, Miller, Haapala, Harnack, Georgieff, Fields, Knights, Jacobs, Seburg, Demerath, Gale and Swanson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Marie Swanson, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.